Market Cap

Grifols, SA Market Capitalization:

€7.62 Billion

EUR as of Jan. 1, 2026

US$8.95 Billion

business Grifols, SA Company Profile

Grifols, SA Main Stock Listing

BME: GRF

Market Capitalization History of Grifols, SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
AstraZeneca $284.38 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Grifols, SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €7.62 B 37.27%
Jan. 1, 2025 €5.55 B -35.00%
Jan. 1, 2024 €8.54 B 24.75%
Jan. 1, 2023 €6.84 B -24.54%
Jan. 1, 2022 €9.07 B -35.76%
Jan. 1, 2021 €14.12 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Grifols, SA Categories

Spain languages Healthcare languages Drug Manufacturers—General
Spain Healthcare Spain Drug Manufacturers—General

Stocks & Indices

Grifols, SA has the following listings and related stock indices.


Stock: BME: GRF

Stock: BMV: GRFPN

Stock: FSX: G0FB

Stock: FSX: OZTA

Stock: NASDAQ: GRFS

Stock: OTC: GIFLF

Stock: OTC: GIFOF

Stock: OTC: GIKLY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.